Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study

OBJECTIVE: To evaluate upadacitinib efficacy and safety dose response in Japanese patients with active RA and an inadequate response to conventional synthetic DMARDs (csDMARDs). METHODS: This was a multicentre, phase IIb/III, dose-ranging study conducted in Japan, in which patients on previously sta...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Rheumatology (Oxford)
Glavni autori: Kameda, Hideto, Takeuchi, Tsutomu, Yamaoka, Kunihiro, Oribe, Motohiro, Kawano, Mitsuhiro, Zhou, Yijie, Othman, Ahmed A, Pangan, Aileen L, Kitamura, Susumu, Meerwein, Sebastian, Tanaka, Yoshiya
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2020
Teme:
Clinical Science
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7590414/
https://ncbi.nlm.nih.gov/pubmed/32277824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa084
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items